CP Kratz, PJ Lupo, K Zelley, J Schienda… - Clinical Cancer …, 2024 - aacrjournals.org
With the increasing use of comprehensive germline genetic testing of children and adolescents with cancer, it has become evident that pathogenic variants (PVs) in adult-onset …
This is a valid argument. However, the use of an extreme phenotype case–control design (eg, by using healthy elderly controls to search for cancer associated genes) has been …
A Montella, M Tirelli, VA Lasorsa, V Aievola… - British Journal of …, 2025 - nature.com
Background Emerging evidence suggests that non-coding somatic single nucleotide variants (SNVs) in cis-regulatory elements (CREs) contribute to cancer by disrupting gene …
M Capasso, C Brignole, VA Lasorsa, V Bensa… - Journal of Translational …, 2024 - Springer
Background Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Although the overall survival of patients with NB has …
ASR Westerveld, GAM Tytgat… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Neuroblastoma survivors have an increased risk of developing subsequent malignant neoplasms (SMNs), but the risk of subsequent nonmalignant neoplasms (SNMNs) …
J Wang, H Li, Y Xue, Y Zhang, X Ma, C Zhou, L Rong… - Neoplasia, 2024 - Elsevier
Neurodevelopmental cell communication plays a crucial role in neuroblastoma prognosis. However, determining the impact of these communication pathways on prognosis is …
M Tirelli, F Bonfiglio, S Cantalupo, A Montella… - Human Genetics, 2024 - Springer
Abstract Genome-Wide Association Studies (GWAS) have been decisive in elucidating the genetic predisposition of neuroblastoma (NB). The majority of genetic variants identified in …
F Fabozzi, R Carrozzo, M Lodi, A Di Giannatale… - Frontiers in …, 2024 - frontiersin.org
The increased availability of genetic technologies has significantly improved the detection of novel germline variants conferring a predisposition to tumor development in patients with …
M Cupit-Link, K Hagiwara, J Zhang… - Research …, 2023 - ncbi.nlm.nih.gov
Despite advances in the treatment of high-risk neuroblastoma, approximately half of these patients die from the disease. Targeted therapy based on synthetic lethality associated with …